[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
Identifieur interne : 000064 ( PubMed/Corpus ); précédent : 000063; suivant : 000065[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
Auteurs : J. Ben Hassouna ; M. Slimène ; H. Boussen ; H. Bouzaiene ; F. Khomsi ; R. Chargui ; L. Kochbati ; M H Mtaallah ; A. Gamoudi ; F. Benna ; M. Hechiche ; K. RahalSource :
- Gynecologie, obstetrique & fertilite [ 1297-9589 ] ; 2007.
English descriptors
- KwdEn :
- Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Breast Neoplasms (chemically induced), Breast Neoplasms (drug therapy), Breast Neoplasms (epidemiology), Breast Neoplasms (radiotherapy), Carcinoma, Ductal, Breast (chemically induced), Carcinoma, Ductal, Breast (epidemiology), Child, Combined Modality Therapy, Female, Hodgkin Disease (drug therapy), Hodgkin Disease (radiotherapy), Humans, Male, Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Radiotherapy (adverse effects), Radiotherapy (methods), Retrospective Studies, Risk Factors, Time Factors, Tunisia (epidemiology).
- MESH :
- geographic , epidemiology : Tunisia.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Radiotherapy.
- chemically induced : Breast Neoplasms, Carcinoma, Ductal, Breast.
- drug therapy : Breast Neoplasms, Hodgkin Disease.
- epidemiology : Breast Neoplasms, Carcinoma, Ductal, Breast.
- methods : Radiotherapy.
- radiotherapy : Breast Neoplasms, Hodgkin Disease.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Adolescent, Adult, Child, Combined Modality Therapy, Female, Humans, Male, Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Retrospective Studies, Risk Factors, Time Factors.
Abstract
Therapeutic results of Hodgkin disease (HD) have improved by the use of combined radio-chemotherapy. However, this association can increase the risk of on-term effects including secondary cancers. In a retrospective study, we collected secondary breast cancer (BC) in patients previously treated with chemoradiotherapy for Hodgkin disease at Salah-Azaïz institute of Tunis.
DOI: 10.1016/j.gyobfe.2007.01.030
PubMed: 17543568
Links to Exploration step
pubmed:17543568Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].</title><author><name sortKey="Ben Hassouna, J" sort="Ben Hassouna, J" uniqKey="Ben Hassouna J" first="J" last="Ben Hassouna">J. Ben Hassouna</name><affiliation><nlm:affiliation>Service de Chirurgie Carcinologique, Institut Salah-Azaïz, Tunis, Tunisie.</nlm:affiliation></affiliation></author><author><name sortKey="Slimene, M" sort="Slimene, M" uniqKey="Slimene M" first="M" last="Slimène">M. Slimène</name></author><author><name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name></author><author><name sortKey="Bouzaiene, H" sort="Bouzaiene, H" uniqKey="Bouzaiene H" first="H" last="Bouzaiene">H. Bouzaiene</name></author><author><name sortKey="Khomsi, F" sort="Khomsi, F" uniqKey="Khomsi F" first="F" last="Khomsi">F. Khomsi</name></author><author><name sortKey="Chargui, R" sort="Chargui, R" uniqKey="Chargui R" first="R" last="Chargui">R. Chargui</name></author><author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name></author><author><name sortKey="Mtaallah, M H" sort="Mtaallah, M H" uniqKey="Mtaallah M" first="M H" last="Mtaallah">M H Mtaallah</name></author><author><name sortKey="Gamoudi, A" sort="Gamoudi, A" uniqKey="Gamoudi A" first="A" last="Gamoudi">A. Gamoudi</name></author><author><name sortKey="Benna, F" sort="Benna, F" uniqKey="Benna F" first="F" last="Benna">F. Benna</name></author><author><name sortKey="Hechiche, M" sort="Hechiche, M" uniqKey="Hechiche M" first="M" last="Hechiche">M. Hechiche</name></author><author><name sortKey="Rahal, K" sort="Rahal, K" uniqKey="Rahal K" first="K" last="Rahal">K. Rahal</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17543568</idno><idno type="pmid">17543568</idno><idno type="doi">10.1016/j.gyobfe.2007.01.030</idno><idno type="wicri:Area/PubMed/Corpus">000064</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000064</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].</title><author><name sortKey="Ben Hassouna, J" sort="Ben Hassouna, J" uniqKey="Ben Hassouna J" first="J" last="Ben Hassouna">J. Ben Hassouna</name><affiliation><nlm:affiliation>Service de Chirurgie Carcinologique, Institut Salah-Azaïz, Tunis, Tunisie.</nlm:affiliation></affiliation></author><author><name sortKey="Slimene, M" sort="Slimene, M" uniqKey="Slimene M" first="M" last="Slimène">M. Slimène</name></author><author><name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name></author><author><name sortKey="Bouzaiene, H" sort="Bouzaiene, H" uniqKey="Bouzaiene H" first="H" last="Bouzaiene">H. Bouzaiene</name></author><author><name sortKey="Khomsi, F" sort="Khomsi, F" uniqKey="Khomsi F" first="F" last="Khomsi">F. Khomsi</name></author><author><name sortKey="Chargui, R" sort="Chargui, R" uniqKey="Chargui R" first="R" last="Chargui">R. Chargui</name></author><author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name></author><author><name sortKey="Mtaallah, M H" sort="Mtaallah, M H" uniqKey="Mtaallah M" first="M H" last="Mtaallah">M H Mtaallah</name></author><author><name sortKey="Gamoudi, A" sort="Gamoudi, A" uniqKey="Gamoudi A" first="A" last="Gamoudi">A. Gamoudi</name></author><author><name sortKey="Benna, F" sort="Benna, F" uniqKey="Benna F" first="F" last="Benna">F. Benna</name></author><author><name sortKey="Hechiche, M" sort="Hechiche, M" uniqKey="Hechiche M" first="M" last="Hechiche">M. Hechiche</name></author><author><name sortKey="Rahal, K" sort="Rahal, K" uniqKey="Rahal K" first="K" last="Rahal">K. Rahal</name></author></analytic><series><title level="j">Gynecologie, obstetrique & fertilite</title><idno type="ISSN">1297-9589</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Breast Neoplasms (chemically induced)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (epidemiology)</term><term>Breast Neoplasms (radiotherapy)</term><term>Carcinoma, Ductal, Breast (chemically induced)</term><term>Carcinoma, Ductal, Breast (epidemiology)</term><term>Child</term><term>Combined Modality Therapy</term><term>Female</term><term>Hodgkin Disease (drug therapy)</term><term>Hodgkin Disease (radiotherapy)</term><term>Humans</term><term>Male</term><term>Neoplasms, Radiation-Induced</term><term>Neoplasms, Second Primary</term><term>Radiotherapy (adverse effects)</term><term>Radiotherapy (methods)</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Time Factors</term><term>Tunisia (epidemiology)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Tunisia</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Radiotherapy</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Hodgkin Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radiotherapy</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term><term>Hodgkin Disease</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Male</term><term>Neoplasms, Radiation-Induced</term><term>Neoplasms, Second Primary</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Time Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Therapeutic results of Hodgkin disease (HD) have improved by the use of combined radio-chemotherapy. However, this association can increase the risk of on-term effects including secondary cancers. In a retrospective study, we collected secondary breast cancer (BC) in patients previously treated with chemoradiotherapy for Hodgkin disease at Salah-Azaïz institute of Tunis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17543568</PMID><DateCreated><Year>2007</Year><Month>6</Month><Day>18</Day></DateCreated><DateCompleted><Year>2007</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2007</Year><Month>6</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1297-9589</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2007</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Gynecologie, obstetrique & fertilite</Title><ISOAbbreviation>Gynecol Obstet Fertil</ISOAbbreviation></Journal><ArticleTitle>[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].</ArticleTitle><Pagination><MedlinePgn>536-40</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Therapeutic results of Hodgkin disease (HD) have improved by the use of combined radio-chemotherapy. However, this association can increase the risk of on-term effects including secondary cancers. In a retrospective study, we collected secondary breast cancer (BC) in patients previously treated with chemoradiotherapy for Hodgkin disease at Salah-Azaïz institute of Tunis.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Between 1975 and 2003, seven patients (six women and one man) treated for HD subsequently developed BC. Mean age at diagnosis of HD was 21 years (12-29). The first treatment was combined chemotherapy (MOPP-ABVD) and radiotherapy for all patients. Radiotherapy was delivered with cobalt 60 with large fields. The median dose was 41.3 Gy (2 Gy/fraction in 6 patients and 3.3 Gy in one).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The breast tumours occurred after a median delay of 204 months (132-276). According to the TNM classification, we showed two stage T2, one stage T3, two stage T4b and two stage T4d. The mean clinical size was 47 mm (25-80 mm). All patients had infiltrating carcinoma. Axillary node histological involvement was found in 6 cases. All patients were treated by mastectomy and chemotherapy. Only one patient had a locoregional irradiation. Median survival was 26.5 months (12-48). Four patients died and three are still alive at respectively 24, 31 and 144 months.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">According to the previous data, breast cancer represents 6.3 to 9% of all second cancers occurring after HD treatment. We conclude that especially young women and girls treated for HD should be carefully monitored. We suggest that secondary BC be sometimes treated by conservative radiosurgical approach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ben Hassouna</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de Chirurgie Carcinologique, Institut Salah-Azaïz, Tunis, Tunisie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slimène</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boussen</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Bouzaiene</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Khomsi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Chargui</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kochbati</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Mtaallah</LastName><ForeName>M H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Gamoudi</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Benna</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Hechiche</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rahal</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>FRE</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Cancer du sein secondaire après traitement pour maladie de Hodgkin. A propos de sept cas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2007</Year><Month>May</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Gynecol Obstet Fertil</MedlineTA><NlmUniqueID>100936305</NlmUniqueID><ISSNLinking>1297-9589</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006689" MajorTopicYN="N">Hodgkin Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009381" MajorTopicYN="Y">Neoplasms, Radiation-Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016609" MajorTopicYN="Y">Neoplasms, Second Primary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014416" MajorTopicYN="N" Type="Geographic">Tunisia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>6</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>6</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17543568</ArticleId><ArticleId IdType="pii">S1297-9589(07)00222-6</ArticleId><ArticleId IdType="doi">10.1016/j.gyobfe.2007.01.030</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000064 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000064 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= CobaltMaghrebV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:17543568
|texte= [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17543568" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CobaltMaghrebV1
| This area was generated with Dilib version V0.6.32. |  |